No Data
No Data
10-Q: Q3 2024 Earnings Report
8-K: Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
10-Q: Q2 2024 Earnings Report
8-K: Zura Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Zura Bio Commences Warrant Exchange Offer and Consent Solicitation
Zura Bio Presents Data for the Tibulizumab (ZB-106) Program at EULAR 2024
FuFu 888 : can we see ur lambo again haha